This site is for general information only and is not medical advice, diagnosis, or treatment. Always talk to a qualified clinician before medical decisions. TrialFinder is not affiliated with trial sponsors or healthcare providers.
The content in this section is written by a patient advocate, not a medical professional. It is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making medical decisions.
Plain-language guides on clinical trials, plus condition guides that map a diagnosis to recruiting studies.
How seizure type, drug resistance, and treatment approach change which epilepsy trials may fit.
How tumor type, grade, and biomarkers such as IDH and MGMT change which trials may fit.
How subtype and biomarkers such as HER2, BRCA, and PIK3CA change which trials may fit.
How resectability and biomarkers such as KRAS, BRCA, and MSI change which trials may fit.
How type and biomarkers such as EGFR, ALK, and KRAS change which trials may fit.
Osimertinib (Tagrisso) for uncommon EGFR mutations such as G719X, S768I, L861Q, and exon 20 insertions: what the evidence covers, plus active clinical trials.
Mental health clinical trials can test medications, psychotherapy, TMS devices, digital therapeutics, and psychedelic-assisted treatment. Here is how they differ from cancer trials, and how to start looking.
What happens between finding a clinical trial and your first visit: screening, the informed consent form, the questions worth asking, common fears answered plainly, and the red flags that should make you walk away.
Moderna and Merck's personalized mRNA cancer vaccine just hit its Phase 3 endpoints in melanoma. Here's what it teaches us about the value of joining clinical trials.